SCHEMBL5627360

SCHEMBL5627360

[SiH3]OC1CNCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11414328 0.80 HTR1A (0.33)
SCHEMBL26499779 0.76
SCHEMBL2124905 0.76
SCHEMBL1484450 0.76
Hydrochloric Acid SCHEMBL27797668 0.74
SCHEMBL14384213 0.73 SSTR4 (0.32)
SCHEMBL2124945 0.71
SCHEMBL1620793 0.71
SCHEMBL22413765 0.71 SLC6A2 (0.34)
SCHEMBL2127211 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070112008-A1 Saframycins, analogues and uses thereof MYERS ANDREW G 2007-05-17 US disclosed
US-7122549-B2 Saframycins, analogues and uses thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2006-10-17 US disclosed
US-6809099-B2 FOR THERAPY OF CANCER PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2004-10-26 US disclosed
US-20040204419-A1 Saframycins, analogues and uses thereof MYERS ANDREW G (US) 2004-10-14 US disclosed
EP-1339713-A2 SAFRAMYCINS, ANALOGUES AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2003-09-03 EP disclosed
US-20030008873-A1 Saframycins, analogues and uses thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-01-09 US disclosed
WO-2002040477-A2 SAFRAMYCINS, ANALOGUES AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2002-05-23 WO disclosed